Karlheinz Peter Selected Research

ST Elevation Myocardial Infarction

2/2023	Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromes.
1/2023	LidocAine Versus Opioids In MyocarDial infarction: the AVOID-2 randomized controlled trial.
4/2021	Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry.
1/2021	An open-label, non-inferiority randomized controlled trial of lidocAine Versus Opioids In MyocarDial Infarction study (AVOID-2 study) methods paper.
1/2021	A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction.
1/2020	Prehospital opioid dose and myocardial injury in patients with ST elevation myocardial infarction.
12/2019	The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.
5/2019	Opioids and ST Elevation Myocardial Infarction: A Systematic Review.
7/2018	Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients.
9/2009	FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karlheinz Peter Research Topics

Disease

40	Inflammation (Inflammations) 04/2024 - 08/2002
37	Thrombosis (Thrombus) 03/2024 - 07/2006
30	Atherosclerosis 03/2024 - 07/2003
23	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 06/2004
23	Myocardial Infarction 02/2023 - 09/2009
18	Atherosclerotic Plaque (Atheroma) 11/2022 - 03/2008
16	Hemorrhage 01/2022 - 07/2006
12	Acute Coronary Syndrome 02/2023 - 02/2002
11	ST Elevation Myocardial Infarction 02/2023 - 08/2007
11	Reperfusion Injury 12/2021 - 09/2009
9	Rupture 01/2022 - 03/2008
8	Neoplasms (Cancer) 01/2023 - 01/2017
8	Ischemia 10/2019 - 09/2011
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 11/2010
7	Chest Pain (Chest Pains) 02/2023 - 12/2016
7	Hypertension (High Blood Pressure) 01/2019 - 06/2004
6	Stroke (Strokes) 05/2024 - 03/2012
6	Pulmonary Embolism 01/2023 - 06/2012
6	Pathologic Constriction (Stenosis) 01/2023 - 07/2013
4	Pain (Aches) 01/2023 - 01/2020
4	Myocarditis (Carditis) 01/2023 - 01/2020
4	Infections 01/2022 - 01/2016
4	Fibrosis (Cirrhosis) 01/2022 - 05/2015
4	Sepsis (Septicemia) 01/2021 - 06/2008
4	Atrial Fibrillation 11/2020 - 07/2010
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 05/2012
3	COVID-19 01/2022 - 01/2020
3	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2011
3	Abdominal Aortic Aneurysm 01/2022 - 10/2014
3	Venous Thromboembolism 01/2022 - 06/2012
3	Infarction (Infarctions) 12/2021 - 01/2018
3	Insulin Resistance 01/2017 - 01/2012
3	Weight Gain 01/2017 - 01/2012
3	Necrosis 12/2016 - 08/2014
3	Carotid Artery Thrombosis 03/2014 - 05/2007
3	Hypothermia 01/2012 - 07/2011
3	Vascular Diseases (Vascular Disease) 11/2008 - 07/2003
2	Ischemic Stroke 05/2024 - 01/2017
2	Wounds and Injuries (Trauma) 11/2023 - 08/2014
2	Weight Loss (Weight Reduction) 06/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2004
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2010
14	Apolipoproteins E (ApoE)IBA 03/2024 - 02/2011
12	C-Reactive ProteinIBA 01/2022 - 07/2009
10	Peptides (Polypeptides)IBA 10/2023 - 01/2009
10	IntegrinsIBA 01/2019 - 02/2002
9	LipidsIBA 10/2023 - 01/2016
8	Opioid Analgesics (Opioids)IBA 02/2023 - 05/2019
8	CytokinesIBA 01/2019 - 03/2008
8	Contrast MediaIBA 07/2017 - 03/2008
7	ApolipoproteinsIBA 03/2024 - 02/2011
7	LigandsIBA 11/2020 - 08/2002
7	AnticoagulantsIBA 10/2020 - 03/2007
7	ferric chlorideIBA 01/2017 - 07/2006
6	Thrombin FDA Link 03/2024 - 08/2007
6	CollagenIBA 03/2024 - 01/2009
5	Adenosine Diphosphate (ADP)IBA 03/2024 - 07/2011
5	omega-Chloroacetophenone (Mace)IBA 02/2023 - 05/2019
5	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2009
5	MicroRNAs (MicroRNA)IBA 10/2020 - 03/2012
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020 - 03/2007
5	EpitopesIBA 01/2019 - 05/2007
5	Glycoproteins (Glycoprotein)IBA 01/2018 - 03/2008
5	ProteomeIBA 01/2017 - 01/2009
4	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2021
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2004
4	FibrinIBA 10/2021 - 03/2007
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2021 - 06/2012
4	AntibodiesIBA 11/2015 - 03/2007
4	P-SelectinIBA 10/2011 - 11/2008
3	Designed Ankyrin Repeat ProteinsIBA 06/2023 - 01/2021
3	Fentanyl (Sublimaze)FDA LinkGeneric 01/2023 - 01/2021
3	Troponin IIBA 01/2023 - 12/2016
3	Lidocaine (Xylocaine)FDA LinkGeneric 01/2023 - 01/2021
3	VaccinesIBA 01/2023 - 12/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2014
3	Complement System Proteins (Complement)IBA 12/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2012
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2017
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 09/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 07/2009
3	Platelet Membrane Glycoprotein IIbIBA 01/2018 - 03/2008
3	Therapeutic UsesIBA 01/2018 - 07/2003
3	HMGB1 Protein (HMG1)IBA 11/2015 - 02/2011
3	Single-Chain AntibodiesIBA 03/2014 - 03/2007
3	CD40 Ligand (CD40L)IBA 01/2012 - 03/2007
2	EnzymesIBA 03/2024 - 01/2018
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2023 - 01/2021
2	CholesterolIBA 01/2023 - 01/2022
2	Thromboplastin (Tissue Factor)IBA 01/2023 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020

Therapy/Procedure

36	Therapeutics 05/2024 - 08/2007
11	Percutaneous Coronary Intervention 01/2022 - 08/2007
8	Precision Medicine 01/2023 - 01/2016
7	Analgesia 02/2023 - 05/2019
4	Thrombolytic Therapy 05/2024 - 01/2016
4	Ligation 01/2022 - 08/2014
4	Denervation 01/2018 - 05/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2004
2	Immunotherapy 01/2023 - 11/2017